In Wake of Q4 Profit, Cepheid Says FIND Will Provide $5M for HIV Viral Load Test

On the heels of a 19 percent spike in fourth-quarter revenues and a quarterly profit, Cepheid said that it will receive $5 million from the Foundation for Innovative New Diagnostics to help accelerate development of a molecular test for HIV viral load.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.